5/18
Penn in the News
A round-up of Penn mentions in local, national, and international media.
Filter Stories
Penn In the News
Only 35% of people eligible for statins use them, study shows. How do you know if you should be on them?
Alexander C. Fanaroff of the Perelman School of Medicine explains how lowering cholesterol with statins can help reduce the risk of a heart attack or stroke.
Penn In the News
Gut health could play a role in how blood cancer patients respond to therapy
Marco Ruella of the Perelman School of Medicine says that researchers need to tackle the problems with CAR T cell therapy to increase survival rates and improve the quality of life for cancer survivors.
Penn In the News
How family history influences your drinking
Henry Kranzler of the Perelman School of Medicine says that complete abstinence is an extreme solution for alcohol use disorder but is the one that works the best.
Penn In the News
This Penn resident is behind an AI app aiming to reduce physician burnout
Penn Medicine resident Nikhil Illa is featured as the cofounder of Pocket Scribe, maker of a cloud-based app that assists physicians by using artificial intelligence to transcribe and sort dictated notes. The app won the Best Pitch Award at Pennovation’s annual accelerator pitch day.
Penn In the News
FDA approves two sickle cell therapies, including first CRISPR medicine
Kiran Musunuru of the Perelman School of Medicine says that gene editing will be the biggest story of the century.
Penn In the News
Millennials and Gen Xers might be the unluckiest caregivers in history. Here’s how their crisis is affecting every workplace
A report by Mary Naylor of the School of Nursing found that many employed caregivers miss work, reduce their work hours, refuse promotions, or leave the workforce altogether to meet family responsibilities.
Penn In the News
Godfather of mRNA vaccines reveals plans to immunize people against cancer years before tumors strike to ‘the disease from ever appearing’
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize for mRNA vaccines along with Katalin Karikó, is researching an mRNA vaccine against cancer.
Penn In the News
A cancer vaccine, glowing tumors, lightning speed radiation: Three UPenn innovations to watch
Robert H. Vonderheide of the Perelman School of Medicine discusses three cancer treatment innovations that could be game changers for patients.
Penn In the News
You should still get the COVID-19 vaccine. The Nobel Prize winner who helped discover it explains why
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
Penn In the News
Most admired CEOs 2023: Kevin Mahoney, University of Pennsylvania Health System
Kevin Mahoney is lauded for his accomplishments as CEO of the University of Pennsylvania Health System.